The solute carrier transporters and the brain:Physiological and pharmacological implications

• 作者: Chengliang Hu Lei Tao Ligong Chen Xizhi Cao
• 来源期刊: 亚洲药物制剂科学(英文)
• 学科: 医学
• 关键词: SOLUTE carrier TRANSPORTER BRAIN DISORDER Blood-brain barrier Drug
• 年，卷（期）: 2020,（2）
• 页码范围: 131-144
• 页数: 14页
• 分类号: R74

摘要

Solute carriers(SLCs)are the largest family of transmembrane transporters that determine the exchange of various substances,including nutrients,ions,metabolites,and drugs across biological membranes.To date,the presence of about 287 SLC genes have been identified in the brain,among which mutations or the resultant dysfunctions of 71 SLC genes have been reported to be correlated with human brain disorders.Although increasing interest in SLCs have focused on drug development,SLCs are currently still under-explored as drug targets,especially in the brain.We summarize the main substrates and functions of SLCs that are expressed in the brain,with an emphasis on selected SLCs that are important physiologically,pathologically,and pharmacologically in the blood-brain barrier,astrocytes,and neurons.Evidence suggests that a fraction of SLCs are regulated along with the occurrences of brain disorders,among which epilepsy,neurodegenerative diseases,and autism are representative.Given the review of SLCs involved in the onset and procession of brain disorders,we hope these SLCs will be screened as promising drug targets to improve drug delivery to the brain.